Brief: Kwangdong Pharmaceutical sees FY 2017 revenue to be 743.2 bln won
24/04/2017 02:40
April 24 (Reuters) - Kwangdong Pharmaceutical Co Ltd
009290.KS :
* Sees FY 2017 revenue to be 743.2 billion won
Source text in Korean: https://goo.gl/96OvWH
Further company coverage: 009290.KS
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on Kwangdong Pharmaceutical
See all newsBrief: Kwangdong Pharmaceutical Q2 Operating Profit 2.8 Billion Won, Down 38% From Year Earlier
Brief: Kwangdong Pharmaceutical To Divest 25 Billion Won Worth Of Own Shares
Brief: Kwangdong Pharmaceutical To Divest 22 Billion Won Worth Of Own Shares
Ocugen up after licensing deal for ophthalmic gene therapy in South Korea
Brief: Kwangdong Pharmaceutical Q1 Operating Profit 3.3 Billion Won, Down 80.6% From Year Earlier